Clinical trial
A Follow-Up Study of Schizophrenic Participants Following Treatment…
NCT00378092 · Janssen Cilag N.V./S.A., Industry · Completed
Key facts
| NCT number | NCT00378092 |
|---|---|
| Title | A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode |
| Official title | A Prospective Study of the Clinical Outcome Following Treatment Discontinuation After Remission in First-Episode Schizophrenia |
| Lead sponsor | Janssen Cilag N.V./S.A., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Oral risperidone, Risperidone Long-Acting Injection (RLAI) |
| Enrollment | 33 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Sep 19, 2006 |
| Last update posted | May 8, 2014 |
| Countries | South Africa |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: